Definium Therapeutics, Inc. (DFTX)
44.81
+1.54
(+3.56%)
USD |
NASDAQ |
Aug 25, 16:00
44.81
0.00 (0.00%)
Pre-Market: 08:12
Definium Therapeutics Total Assets (Quarterly) : 1.113B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.113B |
| March 31, 2026 | 401.29M |
| December 31, 2025 | 440.10M |
| September 30, 2025 | 236.92M |
| June 30, 2025 | 265.09M |
| March 31, 2025 | 275.32M |
| December 31, 2024 | 302.15M |
| September 30, 2024 | 319.77M |
| June 30, 2024 | 268.14M |
| March 31, 2024 | 275.53M |
| December 31, 2023 | 124.54M |
| September 30, 2023 | 141.55M |
| June 30, 2023 | 142.08M |
| March 31, 2023 | 155.53M |
| December 31, 2022 | 169.99M |
| September 30, 2022 | 180.91M |
| June 30, 2022 | 134.28M |
| March 31, 2022 | 149.23M |
| December 31, 2021 | 164.00M |
| Date | Value |
|---|---|
| September 30, 2021 | 178.58M |
| June 30, 2021 | 164.00M |
| March 31, 2021 | 200.79M |
| December 31, 2020 | 85.64M |
| September 30, 2020 | 23.68M |
| June 30, 2020 | 29.85M |
| March 31, 2020 | 26.23M |
| August 31, 2019 | 2.937M |
| May 31, 2019 | 3.543M |
| February 28, 2019 | 3.806M |
| November 30, 2018 | 3.488M |
| August 31, 2018 | 3.533M |
| May 31, 2018 | 3.280M |
| February 28, 2018 | 3.546M |
| November 30, 2017 | 3.746M |
| August 31, 2017 | 4.028M |
| May 31, 2017 | 3.978M |
| February 28, 2017 | 2.217M |
| November 30, 2016 | 0.7788M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 4.649M |
| CNBX Pharmaceuticals, Inc. | 0.0128M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 675.10M |
| Fulcrum Therapeutics, Inc. | 323.95M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 194.22M |
| Shareholders Equity (Quarterly) | 918.68M |
| Debt to Equity Ratio | 0.0397 |
| Current Ratio | 6.947 |
| Net Debt Paydown Yield | -0.05% |